Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 959 of 1,261

  1. US 7977488

    1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Takeda Pharmaceutical Company Limited · Granted Jul 12, 2011 · Expires Jul 7, 2031

    granted

  2. EP 2340815

    Verfahren und Vorrichtung zur Herstellung einer überlappenden Schutzfolie für ein transdermales therapeutisches System

    ACINO AG [DE] · Granted Jul 6, 2011 · Expires Jul 1, 2031

    granted

  3. US 7973075

    Kainate receptor-selective epimeric analogs of dysiherbaine

    Northwestern University · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  4. US 7973162

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  5. US 7973038

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  6. US 7972601

    Method of promoting delivery of an antioxidant agent to a cell expression neuroligin

    The Regents of the University of California · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  7. US 7972854

    Methods and compositions for targeted cleavage and recombination

    Sangamo Biosciences, Inc. · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  8. US 7972813

    Tetrodotoxin-resistant sodium channel alpha subunit

    Vertex Pharmaceuticals Incorporated · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  9. US 7973045

    Anhydrous form of dasatinib and process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  10. US 7972821

    Production of functional proteins: balance of shear stress and gravity

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  11. US 7973020

    Compositions and methods for inhibiting expression of a gene from the ebola virus

    The United States of America as represented by the Secretary of the Army · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  12. US 7973057

    Thalidomide analogs

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  13. US 7973069

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  14. US 7973169

    Modulators of ATP-Binding Cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  15. US 7973163

    Fused quinoline derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  16. US 7972543

    Process for producing microsphere with use of metal substrate having through-hole

    KURARAY CO., LTD. · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  17. US 7972598

    VEGF-binding fusion proteins and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  18. US 7972606

    T24 antigen for immunodiagnosis of Taenia solium cysticercosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  19. US 7972661

    Electrospraying method with conductivity control

    Regents of the University of Minnesota · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  20. US 7972793

    Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype

    SureGene LLC · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted

  21. CA 2785117

    SYSTEME THERAPEUTIQUE TRANSDERMIQUE SERVANT A ADMINISTRER DE LA RIVASTIGMINE OU SES DERIVES

    ACINO AG [DE] · Granted Jun 30, 2011 · Expires Jun 25, 2031

    granted

  22. US 7968115

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  23. US 7968080

    Somatostatin analogs with inhibitory activity to growth hormone release

    The Regents of the University of California · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

  24. US 7968749

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.